D. Foster

发表

Nucleotide sequence of the gene for human factor IX (antihemophilic factor B).

K. Kurachi, E. Davie, S. Yoshitake, 1985, Biochemistry.

Inhibitory properties of human recombinant Arg24-->Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2).

W. Kisiel, D. Foster, S. Kamei, 1999, Thrombosis research.

Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line Cε transcription of IL-4–stimulated B cells

Kotaro Suzuki, Yasushi Saito, H. Nakajima, 2002 .

Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C(epsilon) transcription of IL-4-stimulated B cells.

Kotaro Suzuki, Yasushi Saito, H. Nakajima, 2002, Blood.

Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae

R. G. Anderson, Y. Ying, D. Foster, 1994, The Journal of cell biology.

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

K. Srivenugopal, W. Kisiel, F. Ali-Osman, 2003, Oncogene.

The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice.

W. Kisiel, H. Inzunza, Duan Ma, 2004, Blood.

Propeptide of human protein C is necessary for gamma-carboxylation.

K. Berkner, E. Davie, B. Schach, 1987, Biochemistry.

Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.

P. Libby, W. Kisiel, D. Foster, 2001, The Journal of clinical investigation.

Megakaryocytopoiesis In Vitro: From the Stem Cells' Perspective

D. Foster, S. Jacobsen, M. Murphy, 1996, Stem cells.

Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.

W. Kisiel, H. Blumberg, L. Petersen, 1996, Biochemistry.

Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2.

W. Kisiel, D. Foster, M. Iino, 1998, Arteriosclerosis, thrombosis, and vascular biology.

A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion

C. N. Rao, W. Kisiel, D. Dinh, 2001, Oncogene.

Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2.

C. N. Rao, W. Kisiel, D. Reeder, 1996, Archives of biochemistry and biophysics.

Factor VII Central

D. Bharadwaj, W. Kisiel, D. Foster, 1996, The Journal of Biological Chemistry.

Recombinant ob protein reduces feeding and body weight in the ob/ob mouse.

Janet, T. Bukowski, C. Lofton-Day, 1995, The Journal of clinical investigation.

Thrombopoietin is synergistic with other hematopoietic growth factors and physiologic platelet agonists for platelet activation in vitro

K. Kaushansky, W. Hammond, D. Foster, 1997, American journal of hematology.

Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10.

D. Adler, C. Disteche, W. Hagopian, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of Soluble Recombinant Furin by Human Proteinase Inhibitor 8*

W. Kisiel, D. Foster, F. Jean, 1998, The Journal of Biological Chemistry.

Human proteinase inhibitor 9 (PI9) is a potent inhibitor of subtilisin A.

W. Kisiel, D. Foster, J. Dahlen, 1997, Biochemical and biophysical research communications.

High Concentrations of Thrombopoietin Activate Platelets In Vitro

K. Kaushansky, W. Hammond, T. Wun, 1998 .

The structure, biology and potential therapeutic applications of recombinant thrombopoietin

D. Foster, S. Lok, 1994, Stem cells.

Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo.

R. Paus, D. Foster, S. Bulfone-Paus, 2003, The Journal of investigative dermatology.

Interleukin-21 inhibits dendritic cell activation and maturation.

D. Foster, S. Bulfone-Paus, R. Rückert, 2003, Blood.

Expression, purification and characterization of a Kunitz‐type protease inhibitor domain from human amyloid precursor protein homolog

K. Norris, F. Norris, L. Petersen, 1994, FEBS letters.

Dual Role for Adenine Nucleotides in the Regulation of the Atrial Natriuretic Peptide Receptor, Guanylyl Cyclase-A*

D. Garbers, D. Foster, David L. Garbers, 1998, The Journal of Biological Chemistry.

A mutation of the atrial natriuretic peptide (guanylyl cyclase-A) receptor results in a constitutively hyperactive enzyme.

D. Garbers, D. Foster, B. Wedel, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Cloning and characterization of human protease-activated receptor 4.

Scott R. Presnell, D. Yee, E. Davie, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Signal Transduction via the Mitogen-activated Protein Kinase Pathway Induced by Binding of Coagulation Factor VIIa to Tissue Factor*

L. Poulsen, D. Foster, O. Thastrup, 1998, The Journal of Biological Chemistry.

Paradoxical Pro-invasive Effect of the Serine Proteinase Inhibitor Tissue Factor Pathway Inhibitor-2 on Human Hepatocellular Carcinoma Cells*

W. Kisiel, C. Balabaud, A. Desmoulière, 2000, The Journal of Biological Chemistry.

Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent.

W. Kisiel, D. Foster, C. Sprecher, 1994, Blood.

Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.

W. Kisiel, S. Mathewes, D. Foster, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Molecular cloning of the cDNA for a human amyloid precursor protein homolog: evidence for a multigene family.

F. Grant, P. O'Hara, K. Norris, 1993, Biochemistry.

Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells.

D. Foster, A. Ichinose, H. Kaetsu, 1996, Journal of biochemistry.

Thrombopoietin‐Stimulated ex Vivo Expansion of Human Bone Marrow Megakaryocytes

J. White, A. Rademaker, D. Green, 1996, Stem cells.

Patent Number : ( 45 ) Date of Patent : 5 , 618 , 696 Apr . 8 , 1997 54 HUMAN KUNITZ-TYPE PROTEASE INHIBITOR

D. Foster, C. Sprecher, 2017 .

Interleukin‐21 is a T‐helper cytokine that regulates humoral immunity and cell‐mediated anti‐tumour responses

C. Clegg, D. Foster, P. Sivakumar, 2004, Immunology.

Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.

W. Kisiel, M. Yamamoto, T. Hamamoto, 1993, The Journal of biological chemistry.

Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.

T. Martin, D. Foster, R. Goodman, 1996, Biochemical and biophysical research communications.

Rapid Publication Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob Mice

S. Woods, R. Seeley, M. Schwartz, 1996 .

HT‐1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix‐associated serine protease inhibitor TFPI‐2/33 kDa MSPI

M. Stack, C. N. Rao, W. Kisiel, 1998, International journal of cancer.

High-level expression of recombinant human fibrinogen in the milk of transgenic mice

D. Foster, P. Bishop, D. Prunkard, 1996, Nature Biotechnology.

Resistance to inhibition by alpha-1-anti-trypsin and species specificity of a chimeric human/bovine protein C.

D. Foster, R. Holly, 1994, Biochemistry.

Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.

J. Birktoft, L. Petersen, D. Foster, 1993, Biochemistry.

Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C.

K. Kurachi, E. Davie, D. Foster, 1986, Biochemistry.

Hepsin, a Putative Membrane-associated Serine Protease, Activates Human Factor VII and Initiates a Pathway of Blood Coagulation on the Cell Surface Leading to Thrombin Formation (*)

W. Kisiel, T. Hamamoto, D. Foster, 1995, The Journal of Biological Chemistry.

Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.

W. Kisiel, D. Foster, W Kisiel, 1998, Archives of biochemistry and biophysics.

Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.

W. Kisiel, K. Berkner, T. Nakagaki, 1991, Biochemistry.

Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.

W. Kisiel, L. Thim, Y. Komiyama, 1991, The Journal of biological chemistry.

Structure of the Gene for Human Factor Ix

K. Kurachi, E. Davie, S. Yoshitake, 1985 .

A method for the treatment of inflammation

K. Madden, Wenfeng Xu, S. Jaspers, 2000 .

Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo

Scott R. Presnell, F. Grant, P. O'Hara, 1994, Nature.

Human Plasma and Recombinant Factor VI1

L. Thim, D. Foster, M. Christensen, 1991 .

Interleukin‐21 and the IL‐21 receptor: novel effectors of NK and T cell responses

J. Parrish-Novak, C. Clegg, D. Foster, 2002, Journal of leukocyte biology.

and T cell responses

J. Parrish-Novak, C. Clegg, D. Foster, 2002 .

Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob Mice

S. Woods, R. Seeley, D. Porte, 1996, Diabetes.

Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas

G. Kouraklis, C. N. Rao, W. Kisiel, 2002, Oncogene.

Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene.

W. Kisiel, D. Foster, S. Kamei, 2001, Biochimica et biophysica acta.

Endoproteolytic processing of the human protein C precursor by the yeast Kex2 endopeptidase coexpressed in mammalian cells.

D. Foster, C. Sprecher, A. Kumar, 1991, Biochemistry.

The nucleotide sequence of the gene for human protein C.

E. Davie, S. Yoshitake, D. Foster, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Endoproteolytic processing of the dibasic cleavage site in the human protein C precursor in transfected mammalian cells: effects of sequence alterations on efficiency of cleavage.

D. Foster, C. Sprecher, A. Kumar, 1990, Biochemistry.

Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin

V. Broudy, K. Kaushansky, T. Papayannopoulou, 1994, Nature.

Structure, function and biology of tissue factor pathway inhibitor-2

W. Kisiel, D. Foster, H. Chand, 2005, Thrombosis and Haemostasis.

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), in human glioma cells

K. Srivenugopal, W. Kisiel, F. Ali-Osman, 2003, Oncogene.

Nucleotide Sequence of the Gene Encoding Murine Tissue Factor Pathway Inhibitor-2

W. Kisiel, D. Foster, S. Kamei, 2000, Thrombosis and Haemostasis.

A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist

Scott R. Presnell, F. Grant, S. Dillon, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Molecular cloning of porcine alveolar macrophage-derived neutrophil chemotactic factors I and II; identification of porcine IL-8 and another intercrine-alpha protein.

T. Martin, S. Mathewes, S. Osborn, 1992, Biochemistry.

Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.

W. Kisiel, G. Nelsestuen, D. Foster, 1998, Proceedings of the National Academy of Sciences of the United States of America.

The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues.

W. Kisiel, D. Foster, J. Dahlen, 1998, Biochemical and biophysical research communications.

Response of Factor VIII and IX-Deficient Blood to Wild Type and High Membrane Affinity Mutant Factor VIIa in an In Vitro Whole Blood Clotting Assay: Possible Correlation to Clinical Outcome

W. Kisiel, G. Nelsestuen, N. Key, 2002, Thrombosis and Haemostasis.

Clonage et expression de l'autoantigene decarboxylase de l'acide glutamique d'ilots humains

W. Hagopian, D. Foster, C. Grubin, 1992 .

Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes

K. Madden, Wenfeng Xu, J. Parrish-Novak, 2002, The Journal of Biological Chemistry.

The use of conserved cellulase family-specific sequences to clone cellulase homologue cDNAs from Fusarium oxysporum.

F. Grant, D. Foster, P. Sheppard, 1994, Gene.

Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization.

F. Grant, D. Foster, Vicki McGrane, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Molecular Cloning, Expression, and Partial Characterization of Two Novel Members of the Ovalbumin Family of Serine Proteinase Inhibitors (*)

W. Kisiel, S. Mathewes, D. Foster, 1995, The Journal of Biological Chemistry.

Characterization of a cDNA coding for human protein C.

E. Davie, D. Foster, D Foster, 1984, Proceedings of the National Academy of Sciences of the United States of America.

The Serpin Proteinase Inhibitor 9 Is an Endogenous Inhibitor of Interleukin 1β–Converting Enzyme (Caspase-1) Activity in Human Vascular Smooth Muscle Cells

James L. Young, P. Libby, W. Kisiel, 2000, The Journal of experimental medicine.

Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9.

J. Mankovich, W. Kisiel, D. Giegel, 1999, The Biochemical journal.

Mapping of glutamic acid decarboxylase (GAD) genes.

D. Adler, C. Disteche, Å. Lernmark, 1993, Genomics.

A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons.

R. Axel, D. Garbers, H. Fülle, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Two membrane forms of guanylyl cyclase found in the eye.

D. Garbers, H. Fülle, D. Foster, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Evidence that an Arg79→Gln substitution in human factor VII is not associated with a reduction in coagulant activity

W. Kisiel, D. Foster, Y. Kazama, 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Mechanisms of regulation and functions of guanylyl cyclases.

S. Robinson, D. Garbers, D. Foster, 1999, Reviews of physiology, biochemistry and pharmacology.

Inhibition of neutrophil elastase by recombinant human proteinase inhibitor 9.

W. Kisiel, D. Foster, J. Dahlen, 1999, Biochimica et biophysica acta.

Elimination of the Cys558-Cys566 bond in Lys78-plasminogen--effect on activation and fibrin interaction.

V. Linde, L. Petersen, D. Foster, 1998, European journal of biochemistry.

Expression, purification, and inhibitory properties of human proteinase inhibitor.

W. Kisiel, D. Foster, J. Dahlen, 1997, Biochemistry.